Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

NCT05806047 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor-positive Advanced Breast Cancer

Interventions

DRUG: chidamide combined with fulvestrant

Sponsor

Fudan University